Stanford Seminar - A Tearful Tale of Biodesign

Explore a Stanford seminar where Michael Ackermann, Vice-President of Neuro-Simulation at Allergan, shares his journey from biodesign fellow to med-tech startup CEO. Discover how the acquisition of his tear-stimulation device company by a global pharmaceutical giant is advancing patient care for dry-eye disease. Gain insights into why big tech companies have yet to disrupt healthcare and learn about the resulting opportunities for entrepreneurs in the medical field. Delve into Ackermann's experiences as a Stanford Byers Center for Biodesign graduate and his perspective on the "growth pharma" model in this 54-minute talk that bridges innovation, entrepreneurship, and healthcare advancement.